BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 11387672)

  • 1. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
    Chanock SJ; Walsh TJ
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S15-20. PubMed ID: 8971401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of intractable mycoses].
    Ikemoto H
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1680-4. PubMed ID: 2079591
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic mycotic infections].
    Meunier F
    Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
    Glasmacher A; Just-Nübling G; Molitor E
    Dtsch Med Wochenschr; 1998 Feb; 123(7):191-4. PubMed ID: 9505945
    [No Abstract]   [Full Text] [Related]  

  • 9. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
    Castagnola E; Bucci B; Montinaro E; Viscoli C
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review of antifungal therapy for deep fungal infection.
    Muller RJ
    Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral antifungal agents].
    Tarumoto N; Maesaki S
    Nihon Rinsho; 2008 Dec; 66(12):2373-7. PubMed ID: 19069108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of systemic fungal infections: alternatives to itraconazole.
    Herbrecht R; Nivoix Y; Fohrer C; Natarajan-Amé S; Letscher-Bru V
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i39-i48. PubMed ID: 16120633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approach to the acute management of cryptococcal infections.
    Powderly WG
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract]   [Full Text] [Related]  

  • 15. Current and future therapy of invasive fungal infections.
    Andriole VT
    Curr Clin Top Infect Dis; 1998; 18():19-36. PubMed ID: 9779349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of visceral mycoses, with special reference to drug therapy].
    Ikemoto H
    Nihon Rinsho; 1980 Nov; 38(11):4386-92. PubMed ID: 7253229
    [No Abstract]   [Full Text] [Related]  

  • 17. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.